Moreover, there was evidence of increasing CD8 and CD4 T cells and NK cells within hepatic metastases after treatment, along with increased TLR and IFN signaling and Th1 T cell activation by gene expression analysis, suggesting tumor inflammation as a mechanism of response [28]. The gene discussed is CD8A; the disease is neoplasm.